The High‐Intrinsic Diels−Alder Reactivity of (−)‐Galiellalactone; Generating Four Quaternary Carbon Centers under Mild Conditions

Abstract

The Interleukin‐6 (IL‐6) responsive JAK/STAT pathway seems to be correlated with major diseases such as chronic inflammation, arteriosclerosis, liver fibrosis, Parkinson and Alzheimer disease. In order to take a look at (−)‐galiellalactone as a potential low‐molecular‐weight lead structure for non‐proteinogenic IL‐6 antagonists we carried out a microderivatization program that was aiming at bioactive congeners of the natural product and a preliminary structure‐activity relationship. During this effort, galiellalactone showed reactivity generally governed by convex‐concave face selectivity. O‐Acyl derivatives of galiellalactone turned out to be precursors of bis(dehydratogaliellalactone), a novel oligocyclic Diels−Alder product of complicated architecture. During this extraordinary Diels−Alder‐type conversion four quaternary carbon centers were generated at room temperature under mild conditions in a regio‐ and stereoselective fashion. The novel Diels−Alder transformation was used for a stereoselective hetero‐derivatization of the natural product leading to an aza congener of altered IL‐6 antagonistic activity in HepG2 hepatoma cells. The absolute (4S,5aR,7aR,7bS) configuration of natural (−)‐galiellalactone was confirmed by X‐ray crystallography with Cu‐Kα radiation. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)

Oligothiophene Isothiocyanates as Fluorescent Markers

“…In these cases, the laborious handling of protecting groups is a prerequisite for sufficient chemical selectivity and acceptable yields. With smaller natural products, decorating derivatization often fails to yield bioactive congeners for a different reason:160 the few functional groups present are important for target interaction and decorating the molecule merely results in the futile masking of pharmacophores. This kind of chemical “baroquization” has stigmatized many natural products as being nonoptimizable.…”

STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment

“…Galiellalactone (37,Chart (5) and Table 5), a fungal metabolite from the ascomycete Galiella rufa, has been shown to inhibit the IL-6 signalling pathway by interfering with STAT3 signaling [92,93]. Galiellalactone (37) was isolated during screening of mycelial cultures in the search for inhibitors of the IL-6-mediated signaling pathway, and showed promising inhibitory effects on IL-6-dependent signal transduction in human hepatocellular carcinoma (HepG2) cells.…”

Preclinical and Clinical Perspective on Fungal Metabolites and Their Analogs as Anticancer Agents – From Bench to Bedside

“…GL structure has been determined by X-ray crystallography (Fig. 1) [160] and found to contain a reactive α, β-unsaturated lactone which functionally enhances its affinity towards biological nitrogen-and sulfur-nucleophiles including cysteine to produce inactive adducts [161,162]. GL has also been synthetically produced [163].…”